An unusual form of autoimmune hepatitis in young Somalian men

被引:33
作者
D'Souza, R
Sinnott, P
Glynn, MJ
Sabin, CA
Foster, GR
机构
[1] Barts & London Queen Marys Sch Med & Dent, Inst Cellular & Mol Sci, Hepatobiliary Grp, London, England
[2] UCL Royal Free & Univ Coll Med, Dept Immunol, London, England
[3] UCL Royal Free & Univ Coll Med, Dept Primary Care & Populat Sci, London, England
关键词
autoimmune hepatitis; immuno-suppressive therapy; Somalian men;
D O I
10.1111/j.1478-3231.2005.01088.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Significant diversity in disease severity has been identified for autoimmune disorders among different ethnic groups. Current knowledge of both the natural history and management of autoimmune hepatitis (AIH) has been derived from European or Japanese patients, and there is limited information about the disease in patients from other ethnic groups. Aims: To assess the clinical, histological and immunological features of AIH in patients from Somalia and to determine their response to therapy. Methods: Retrospective review of a cohort of young Somalian men with atypical AIH compared with a control group of European patients. Results: The six Somalian men were younger at presentation (median age 37 (range 24-59) years) than the seven female and three male European controls (55 (34-54) years, P=0.06). The Somalians had slightly more severe disease at presentation-median modified Ishak stage of 2.5 compared with 2 in Europeans (P=0.61) and four (66%) had features of cholestasis compared with only one (10%) European patient (P=0.04). Therapy with prednisolone and azathioprine was completely effective for eight of 10 Europeans but only one of seven Somalians (P=0.04). Analysis of human leucocyte antigen types revealed differences between the Somalian and European patients, although these differences did not reach statistical significance. Conclusion: Somalian men with AIH present with cholestatic features and respond poorly to standard immunosuppressive regimes.
引用
收藏
页码:325 / 330
页数:6
相关论文
共 24 条
[1]   Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome [J].
Abdo, AA ;
Bain, VG ;
Kichian, K ;
Lee, SS .
HEPATOLOGY, 2002, 36 (06) :1393-1399
[2]   International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].
Alvarez, E ;
Berg, PA ;
Bianchi, FB ;
Bianchi, L ;
Burroughs, AK ;
Cancado, EL ;
Chapman, RW ;
Cooksley, WGE ;
Czaja, AJ ;
Desmet, VJ ;
Donaldson, RT ;
Eddleston, ALWF ;
Fainboim, L ;
Heathcote, J ;
Homberg, JC ;
Hoofnagle, JH ;
Kakumu, S ;
Krawitt, EL ;
Mackay, IR ;
MacSween, RNM ;
Maddrey, WC ;
Manns, MP ;
McFarlane, IG ;
zum Büschenfelde, KHM ;
Mieli-Vergani, G ;
Nakanuma, Y ;
Nishioka, M ;
Penner, E ;
Porta, G ;
Portmann, BC ;
Reed, WD ;
Rodes, J ;
Schalm, SW ;
Scheuer, PJ ;
Schrumpf, E ;
Seki, T ;
Toda, G ;
Tsuji, T ;
Tygstrup, N ;
Vergani, D ;
Zeniya, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938
[3]   Development of proliferative diabetic retinopathy in African-Americans and whites with type 1 diabetes [J].
Arfken, CL ;
Reno, PL ;
Santiago, JV ;
Klein, R .
DIABETES CARE, 1998, 21 (05) :792-795
[4]  
Bittencourt PL, 1999, AM J GASTROENTEROL, V94, P1906
[5]  
CHOCAIR P, 1993, QJM, V83, P359
[6]  
Czaja AJ, 1997, HEPATOLOGY, V25, P317
[7]   AUTOIMMUNE HEPATITIS - EVOLVING CONCEPTS AND TREATMENT STRATEGIES [J].
CZAJA, AJ .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (02) :435-456
[8]   Diagnosis and treatment of autoimmune hepatitis [J].
Czaja, AJ ;
Freesel, DK .
HEPATOLOGY, 2002, 36 (02) :479-497
[9]  
Czaja Albert J., 2000, Hepatology, V31, P1194, DOI 10.1053/he.2000.5980
[10]   SUSCEPTIBILITY TO AUTOIMMUNE CHRONIC ACTIVE HEPATITIS - HUMAN-LEUKOCYTE ANTIGENS-DR4 AND ANTIGEN-A1-B8-DR3 ARE INDEPENDENT RISK-FACTORS [J].
DONALDSON, PT ;
DOHERTY, DG ;
HAYLLAR, KM ;
MCFARLANE, IG ;
JOHNSON, PJ ;
WILLIAMS, R .
HEPATOLOGY, 1991, 13 (04) :701-706